ARCHIVES

NCI’s Plan to Limit Growth of Core Grants Prompts Smaller Cancer Centers to Cry Foul

This article is from The Cancer Letter archive.

Vol. 38 No. 19 | May 11, 2012

Download PDF Visit The Full Archive

Related Articles

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

Neuro-Oncologist Schold Leaves Duke For UPCI; Rosner Leads Institute At Chicago.

September 1, 2000

FDA Approves Imaging System To Detect Cervical Pre-Cancer

March 31, 2006

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Letter: Weinstein’s Former Fellows Express “Shock” At Allegations

December 1, 1995

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005